Thus, these studies provide the evidence that OLFM4 is important for the engraftment of primitive leukemia cells in vivo, although it has yet to be determined whether OLFM4 knockdown affects bone marrow homing or in vivo survival of CML lin−CD34+ cells. This evidence concerns the gene OLFM4 and chronic myelogenous leukemia, BCR-ABL1 positive.